table of content
1 Introduction to Research & Analysis Reports
1.1 Next-Generation Breast Cancer Diagnostic and Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next-Generation Breast Cancer Diagnostic and Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next-Generation Breast Cancer Diagnostic and Screening Overall Market Size
2.1 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size: 2022 VS 2029
2.2 Global Next-Generation Breast Cancer Diagnostic and Screening Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next-Generation Breast Cancer Diagnostic and Screening Players in Global Market
3.2 Top Global Next-Generation Breast Cancer Diagnostic and Screening Companies Ranked by Revenue
3.3 Global Next-Generation Breast Cancer Diagnostic and Screening Revenue by Companies
3.4 Top 3 and Top 5 Next-Generation Breast Cancer Diagnostic and Screening Companies in Global Market, by Revenue in 2022
3.5 Global Companies Next-Generation Breast Cancer Diagnostic and Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next-Generation Breast Cancer Diagnostic and Screening Players in Global Market
3.6.1 List of Global Tier 1 Next-Generation Breast Cancer Diagnostic and Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Next-Generation Breast Cancer Diagnostic and Screening Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Market Size Markets, 2022 & 2029
4.1.2 Real-Time PCR (q-PCR)
4.1.3 Immunohistochemistry (IHC)
4.1.4 Next-Generation Sequencing (NGS)
4.1.5 Fluorescent In-Situ Hybridization (FISH)
4.2 By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue & Forecasts
4.2.1 By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2018-2023
4.2.2 By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2024-2029
4.2.3 By Type - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2022 & 2029
5.1.2 Hospital-associated Labs
5.1.3 Cancer Research Institutes
5.1.4 Diagnostic Centers
5.2 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue & Forecasts
5.2.1 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2018-2023
5.2.2 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2024-2029
5.2.3 By Application - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2022 & 2029
6.2 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue & Forecasts
6.2.1 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2018-2023
6.2.2 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2024-2029
6.2.3 By Region - Global Next-Generation Breast Cancer Diagnostic and Screening Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2018-2029
6.3.2 US Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.3.3 Canada Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.3.4 Mexico Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2018-2029
6.4.2 Germany Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.4.3 France Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.4.4 U.K. Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.4.5 Italy Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.4.6 Russia Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.4.7 Nordic Countries Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.4.8 Benelux Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2018-2029
6.5.2 China Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.5.3 Japan Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.5.4 South Korea Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.5.5 Southeast Asia Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.5.6 India Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2018-2029
6.6.2 Brazil Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.6.3 Argentina Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next-Generation Breast Cancer Diagnostic and Screening Revenue, 2018-2029
6.7.2 Turkey Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.7.3 Israel Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.7.4 Saudi Arabia Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
6.7.5 UAE Next-Generation Breast Cancer Diagnostic and Screening Market Size, 2018-2029
7 Next-Generation Breast Cancer Diagnostic and Screening Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.1.4 Abbott Laboratories Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Agendia
7.2.1 Agendia Company Summary
7.2.2 Agendia Business Overview
7.2.3 Agendia Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.2.4 Agendia Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.2.5 Agendia Key News & Latest Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Company Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.3.4 Agilent Technologies Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.3.5 Agilent Technologies Key News & Latest Developments
7.4 Ambry Genetics
7.4.1 Ambry Genetics Company Summary
7.4.2 Ambry Genetics Business Overview
7.4.3 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.4.4 Ambry Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.4.5 Ambry Genetics Key News & Latest Developments
7.5 Biocept
7.5.1 Biocept Company Summary
7.5.2 Biocept Business Overview
7.5.3 Biocept Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.5.4 Biocept Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.5.5 Biocept Key News & Latest Developments
7.6 Biotheranostics
7.6.1 Biotheranostics Company Summary
7.6.2 Biotheranostics Business Overview
7.6.3 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.6.4 Biotheranostics Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.6.5 Biotheranostics Key News & Latest Developments
7.7 Centogene
7.7.1 Centogene Company Summary
7.7.2 Centogene Business Overview
7.7.3 Centogene Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.7.4 Centogene Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.7.5 Centogene Key News & Latest Developments
7.8 Danaher Corporation
7.8.1 Danaher Corporation Company Summary
7.8.2 Danaher Corporation Business Overview
7.8.3 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.8.4 Danaher Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.8.5 Danaher Corporation Key News & Latest Developments
7.9 EXACT Sciences Corporation
7.9.1 EXACT Sciences Corporation Company Summary
7.9.2 EXACT Sciences Corporation Business Overview
7.9.3 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.9.4 EXACT Sciences Corporation Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.9.5 EXACT Sciences Corporation Key News & Latest Developments
7.10 Roche Holding AG
7.10.1 Roche Holding AG Company Summary
7.10.2 Roche Holding AG Business Overview
7.10.3 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.10.4 Roche Holding AG Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.10.5 Roche Holding AG Key News & Latest Developments
7.11 Fulgent Genetics
7.11.1 Fulgent Genetics Company Summary
7.11.2 Fulgent Genetics Business Overview
7.11.3 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.11.4 Fulgent Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.11.5 Fulgent Genetics Key News & Latest Developments
7.12 Illumina
7.12.1 Illumina Company Summary
7.12.2 Illumina Business Overview
7.12.3 Illumina Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.12.4 Illumina Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.12.5 Illumina Key News & Latest Developments
7.13 Invitae
7.13.1 Invitae Company Summary
7.13.2 Invitae Business Overview
7.13.3 Invitae Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.13.4 Invitae Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.13.5 Invitae Key News & Latest Developments
7.14 Lucence Diagnostics Pte Ltd
7.14.1 Lucence Diagnostics Pte Ltd Company Summary
7.14.2 Lucence Diagnostics Pte Ltd Business Overview
7.14.3 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.14.4 Lucence Diagnostics Pte Ltd Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.14.5 Lucence Diagnostics Pte Ltd Key News & Latest Developments
7.15 Myriad Genetics
7.15.1 Myriad Genetics Company Summary
7.15.2 Myriad Genetics Business Overview
7.15.3 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Major Product Offerings
7.15.4 Myriad Genetics Next-Generation Breast Cancer Diagnostic and Screening Revenue in Global Market (2018-2023)
7.15.5 Myriad Genetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
